Leading the Fight to treat and cure
Tay-Sachs, Canavan, Sandhoff, GM1 and related diseases

2017 Imagine & Believe



A Night of Fun & Philanthropy
A Benefit for National Tay-Sachs & Allied Diseases Association

Thursday, November 9th

6-9 pm
Royal Sonesta Hotel
40 Edwin Land Blvd
Cambridge, MA

Dinner | Auction | Program


Donate Today  - View list of Donors


Silent Auction

Take a peek at our silent auction offerings here and be ready to bid!



Join our generous sponsors to support NTSAD's 60th Anniversary here.


Program Book Ad

Commemorate this landmark celebration of achievement by recognizing your loved one, your family, your Rare GENEius, or your friends, with an ad in the Gala Program book (available on November 9th or by mail!) 
Submit your ad with this form here or online here by October 18, 2017.
RSVP online here. Deadline to RSVP is October 30th. 

If you're not able to attend, we hope you make a gift HERE in honor of our 60th Anniversary.


Nominate a Rare GENEius

Learn how you can nominate one or more Rare GENEiuses in your life here and their picture will be included in our Community of Support Circle on display at Imagine & Believe and the 40th Annual Family Conference.


Help us to honor Dr.David Meeker and Professor Timothy Cox!

David Meeker,MD- Following 23 years of leadership and unparalleled distinction with research giant Sanofi Genzyme as head of their rare disease, multiple sclerosis,oncology, and immunology business, Dr. Meeker joined KSQ Therapeutics in September 2017. 

A Cambridge-based start-up, KSQ is pioneering CRISPR genome screening technology to identify targets for cancer and immune disease drugs; and better understand the function of each gene across more than 600 tumor and immune models.

Dr.Meeker received his MD from the University of Vermont Medical School. he completed the Advanced Management Program at Harvard Business School in 2000.

Professor Timothy Cox, FMedSci- Professor Timothy Cox is Director of Research and Professor of Medicine Emeritus in the Department of Medicine and Life Fellow of Sidney Sussex College at the University of Cambridge.

The current scientific focus of the Cox laboratory is translational: therapeutic research into intractable sphingolipid disordersthat affect the nervous system - including Gaucher, Krabbe and Tay-Sachs diseases. After nearly two decades of preclinical research with Dr MB Cachón-González, a gene therapy programme for Tay-Sachs and related diseases, sponsored by Cambridge University Health Partners, is now in clinical development.

A Fellow of the Royal College of Physicians of London since 1984, he was elected to Fellowship of the Academy of Medical Sciences in 1998.He holds doctoral degrees from London and Cambridge.


2017 Honorees


Professor Timothy Cox
Director of Research and
Professor of Medicine
University of Cambridge


David Meeker, MD
Former CEO
Genzyme, a Sanofi company


Our Sponsors


Sanofi Genzyme 


Mathew Forbes Romer Foundation 


Amicus Therapeutics 

Audentes Therapeutics 



Cydan Development 

Health Advances 

Horizon Government Affairs 

Joan and Tim Keutzer 

Blyth, Charlie & Gay Lord and Jim & Lyn Taylor 



Acom Healthcare 

Adelman Associates 

Brammer Bio 

Consero Global 


Ruth & Ed Feldman 

Jayne & Bruce Gershkowitz 

The Hamilton Company 

Staci Kallish & Chris Beer 

KOGS Communication 

KSQ Therapeutics 

Alison & Tim Lord 

Massachusetts Biotechnology Council 

Northeast Clinical Services 


Dr. Alan E. Smith & Mrs. Leigh Dunworth and

Drs. Richard & Gillian Gregory 

Speak Life Sciences 

UMass Medical School

Join these sponsors and many others with a sponsorship here. 



Enter your email to receive NTSAD's Topic of the Week or quarterly news.